Principles of prescribing and guidelines for use of topical steroids in dermatology practice
Keywords:
Corticosteroids, topical, guidelinesAbstract
Corticosteroids have been proven invaluable topical agents in treating a variety ofinflammatory conditions affecting skin. They are to be used with caution in any patient inorder to avoid untoward effects, which can be mild and respond readily to discontinuation ofthe corticosteroid agent, or be severe and even life-threatening in their impact. Not only mustthe agent used and its potency be considered when prescribing, but the properties of itsvehicle, duration of therapy, and site of application can all affect the degree of systemicabsorption and severity of side effects. None of these products can be considered safe underall circumstances. Some general principles and guidelines on prescribing topical steroids arediscussed in this article.References
Kastrup EK, ed. Drug Facts and
Comparisons. St. Louis: Wolters
Kluwer Health; 2000.
Lee NP, Arriola ER. Topical steroids:
back to basics. West J Med 1999; 171:
-3.
Katz HI. Topical corticosteroids.
Dermatol Clin 1995; 13: 805-15.
Yohn JJ, Weston WL. Topical
glucocorticosteroids. Curr Probl
Dermatol 1990; 2: 31-63.
National Prescribing Center. Using
topical corticosteroids in general
practice. MeRec Bull 1999; 10: 21-5.
Bucks DA, McMaster JR, Maibach HI
et al. Bioavailability of topically
administered steroids: a mass balance
technique. J Invest Dermatol 1988; 91:
-33.
Jackson DB, Thompson C, McCormack
JR et al. Bioequivalence
(bioavailability) of generic topical
corticosteroids. J Am Acad Dermatol
; 20: 791-6.
Lagos BR, Maibach HI. Frequency of
application of topical corticosteroids: a
review. Br J Dermatol 1998; 139: 763-
Schlagel CA, Sanborn EC. The weights
of topical preparations required for total
and partial body inunction. J Invest
Dermatol 1964; 42: 253-6.
Hepburn D, Yohn JJ, Weston WL.
Topical steroid treatment in infants,
children and adolescents. Adv Dermatol
; 9: 225-54.
Gilbertson EO, Spellman MC,
Piacquadio DJ, Mulford MI.
Superpotent topical corticosteroid use
associated with adrenal suppression:
clinical considerations. J Am Acad
Dermatol 1998; 38: 318-21.
Katz HI, Prawer SE, Medansky RS et
al. Intermittent corticosteroid
maintenance treatment of psoriasis: a
double-blind multicenter trial of
augmented betamethasone dipropionate
ointment in a pulse dose treatment
regimen. Dermatologica 1991; 183:
-74.
Prawer SE, Katz HI. Guidelines to
using superpotent topical steroids. Am
Fam Physician. 1990; 41: 1531-8.
Drake LA, Dinehart SM, Farmer ER et
al. Guidelines of care for the use of
topical glucocorticosteroids. American
Academy of Dermatology. J Am Acad
Dermatol 1996; 35: 615-9.
